Trial Profile
Proof of concept trial of levodopa-deuterated (SD 1077)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 24 Mar 2017
Price :
$35
*
At a glance
- Drugs Levodopa deuterated (Primary)
- Indications Parkinson's disease
- Focus Proof of concept; Therapeutic Use
- Sponsors Auspex Pharmaceuticals
- 27 Jan 2015 New trial record
- 12 Jan 2015 This trial is expected to be initiated and data reported in 2016, according to an Auspex Pharmaceuticals media release